CSBIO
30025524.963.53% ( +0.85 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: CSBIO(300255) the Revenue is 256.1 M (-1%);the EBIT is 24.7 M (+3.6%);the EPS is 0.0064 (+56.1%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.26B1.00%
----
----
EBIT
0.02B3.60%
----
----
EPS
0.006456.10%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf